Received Apr 23, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARCEL | VARICELLA (VARIVAX) | MERCK & CO. INC. | UNK | Y013347 | — |
A HCP called to report that a shipment of VARIVAX was received on 02/23/2025 and inadvertently placed in the refrigerator until a dose of the VARIVAX was inadvertently administered to a patient on 03/09/2025 in which the improper storage was identifi; The HCP reported that the patient did not experience any adverse issues or side effects from the administered dose.; This spontaneous report has been received from a pharmacist, regarding to a patient of 36-years-old of unknown gender. The patient's pertinent medical history, concurrent conditions, concomitant medications, and previous drug reactions or allergies were not reported. On an unknown date, the patient was vaccinated with improperly stored of Varicella Virus Vaccine Live (Oka-Merck) lyophilisate and solvent for solution for injection (VARIVAX) at a dose of 0.5 milliliters (ml), once, (lot number Y013347, expiration date 02-AUG-2026), with a sterile diluent, solution for injection (lot number 2053173, expiration date 23-MAR-2027) both administered as prophylaxis. The administered dose was stored at a temperature of 41.1 degrees Fahrenheit (F) during a time frame of 14 days (product storage error). There was no previous temperature excursion. No additional side effects were reported in the patients.
MERCK STERILE DILUENT